Astragaloside IV is a bioactive saponin compound isolated from the root of Astragalus membranaceus, a plant with a long history in traditional Chinese medicine. Research suggests it may support immune function by modulating various immune cell activities, and studies indicate it has drawn particular scientific interest for its potential anti-aging properties, partly linked to its ability to activate telomerase, an enzyme involved in maintaining chromosome integrity during cell division. Preliminary research also points to wound-healing benefits, with some studies observing that Astragaloside IV may promote tissue repair by enhancing antioxidant defenses and supporting cellular migration to injury sites. While these findings are promising, much of the evidence comes from animal and cell-based studies, and further human clinical trials are needed to confirm these effects.
Compare this supplementResearch suggests that astragaloside IV demonstrates meaningful anti-aging activity across multiple biological system...
View studies →Research suggests that astragaloside IV (AS-IV) exerts a broad range of immune-modulating effects, with studies point...
View studies →Research suggests that astragaloside IV may support wound healing through multiple complementary mechanisms, includin...
View studies →These are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Capsule | 10–40 mg | Daily | Immune function enhancement | Doses used in immunomodulatory RCTs and pilot studies |
| Extract | 25–50 mg | Daily | Anti-aging and telomere support | Common in clinical trials examining telomerase activation and cellular aging |
| Extract | 5–20 mg | Daily | General health and antioxidant support | Lower range observed in early-phase and safety studies |
| Topical | 0.1–1 mg | As needed | Wound healing and skin repair | Concentrations used in preclinical and early clinical wound-healing research |